Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice

Gut

Volumn 55, Issue 1, 2006, Pages 105-113

  Ogawa, A ^a   Tagawa, T ^a   Nishimura, H ^a   Yajima, T ^a   Abe, T ^b   Arai, T ^b   Taniguchi, M ^c   Takeda, K ^a   Akira, S ^d   Nimura, Y ^b   Yoshikai, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BACTERIAL TRANSLOCATION; BILE DUCT LIGATION; CHOLESTASIS; FLOW CYTOMETRY; GENE MUTATION; LIVER; LIVER HISTOLOGY; LIVER INJURY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; BACTERIAL TRANSLOCATION; CHOLESTASIS, EXTRAHEPATIC; FAS LIGAND PROTEIN; FECES; FEMALE; HEPATOCYTES; IMMUNOGLOBULIN A; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PEYER'S PATCHES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTORS;

EID: 29244468007     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.065318     Document Type: Article

References (50)

1. Hashimoto C, Hudson KL, Anderson KV. The Toll gene of Drosophia, required for dorsal-ventral embryonic polarity appears to encode a transmembrane protein. Cell 1988;52:269-79.
2. Lemaitre B, Nicolas E, Michaut L, et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973-83.
3. Hoffmann JA, Kafatos FC, Janeway CA Jr, et al. Phylogenetic perspectives in innate immunity. Science 1999;284:1313-18.
4. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
5. Lien E, Sellati TJ, Yoshimura A, et al. Toll-like receptor 2 functions as a pattern-recognition receptor for diverse bacterial products. J Biol Chem 1999;274:33419-25.
6. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-51.
7. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-71.
8. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in the tlr4 gene. Science 1998;282:2085-8.
9. Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999;285:732-6.
10. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-5.
11. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-103.
12. Lena A, Agnieszka CH, Ruslan M, et al. Recognition of double-stranded RNA and activation of NF-B by Toll-like receptor 3. Nature 2001;413:732-8.
13. Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002;3:196-200.
14. Lolis E, Bucala R. Therapeutic approaches to innate immunity: severe sepsis and septic shock. Nat Rev Drug Discov 2003;2:635-45.
15. Sato S, Takeuchi O, Fujita T, et al. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol 2002;14:783-91.
16. Mokuno Y, Matsuguchi T, Takano M, et al. Expression of Toll-like receptor 2 on γδ T cells bearing invariant Vγ6/Vδ1 indyced by Escherichia coli infection. J Immunol 2000;165:931-40.
17. Shimizu H, Matsuguchi T, Fukuda Y, et al. Toll-like receptor 2 contributes to liver injury induced by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 2002;123:1265-77.
18. Hiromatsu T, Matsuguchi T, Shimizu H, et al. NK T cells stimulated with a ligand for TLR2 contribute to liver injury caused by Escherichia coli infection in mice. Eur J Immunol 2003;33:2511-19.
19. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994;57:316-36.
20. Dixon JM, Armstrong CP, Duffy SW, et al. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 1983;24:845-52.
21. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-27.
22. Deitch EA, Sittig K, Li M, et al. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990;159:79-84.
23. Slocum MM, Sittig KM, Specian RD, et al. Absence of intestinal bile promotes bacterial translocation. Am Surg 1992;58:305-10.
24. Clements WD, Parks R, Erwin P, et al. Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 1996;39:587-93.
25. Sheen-Chen SM, Chau P, Harris HW. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J Surg Res 1998;80:205-9.
26. Arai T, Yoshikai Y, Kamiya J, et al. Bilirubin impairs bactericidal activity of neutrophils through an antioxidant mechanism in vitro. J Surg Res 2001;96:107-13.
27. Yamamoto S, Kubota Y, Tsuji K, et al. Effect of obstructive jaundice on neutrophil chemotactic activity: an in vivo assessment in zymosan-induced peritonitis model in rats. J Gastroenterol Hepatol 1998;13:405-11.
28. Tjandra K, Woodman RC, Swain MG. Impaired neutrophil microbicidal activity in rat cholestasis. Gastroenterology 1997;112:1692-8.
29. Schmucker DL, Ohta M, Kanai S, et al. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990;12:1216-21.
30. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994;94:2183-92.
31. Benz C, Angermuller S, Tox U, et al. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol 1998;28:99-106.
32. Rodrigues CM, Fan G, Wong PY, et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998;4:165-78.
33. Rodrigues CMP, Fan G, Xiaoming M, et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998;101:2790-9.
34. Webster CR, Anwer MS. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 1998;27:1324-31.
35. Faubion WA, Guicciardi ME, Miyoshi H, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999;103:137-45.
36. Miyoshi H, Rust C, Roberts PJ, et al. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999;117:669-77.
37. Canbay A, Higuchi H, Bronk SF, et al. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002;123:1323-30.
38. Cui J, Shin T, Kawano T, et al. Requirement for Valpha 14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;285:732-6.
39. Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 2003;3:63-72.
40. Wang J, Watanabe T. Expression and function of Fas during differentiation and activation of B cells. Int Rev Immunol 1999;18:367-79.
41. Kehry MR. CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. J Immunol 1996;156:2345-8.
42. Carey GB, Donjerkovic D, Mueller CM, et al. B-cell receptor and Fas-mediated signals for life and death. Immunol Rev 2000;176:105-15.
43. Onel KB, Tucek-Szabo CL, Ashany D, et al. Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny. Eur J Immunol 1995;25:2940-7.
44. Mandik L, Nguyen KA, Erikson J. Fas receptor expression on B-lineage cells. Eur J Immunol 1995;25:3148-54.
45. Watanabe D, Suda T, Nagata S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int Immunol 1995;7:1949-56.
46. Fukuyama H, Adachi M, Suematsu S, et al. Requirement of Fas expression in B cells for tolerance induction. Eur J Immunol 2002;32:223-30.
47. Ayala A, Xin Xu Y, Ayala CA, et al. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 1998;91:1362-72.
48. Chung CS, Wang W, Chaudry IH, et al. Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. Am J Physiol Gastrointest Liver Physiol 2001;280:812-18.
49. Tibbetts MD, Zheng L, Lenardo MJ. The deam effector domain protein family: regulators of cellular homeostasis. Nat Immunol 2003;4:404-9.
50. Thome M, Tschopp J. Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 2001;1:50-8.